德国IonGate Biosciences GmbH 
IonGate Biosciences develops, produces and markets innovative screening technologies to investigate transporters and is the worldwide leader in this new area.

Transporters are essential for the metabolic functions of the cell, information processing in the entire organism, and play a fundamental role in the health of humans. Due to their difficult experimental accessibility, transporters are underrepresented in current drug screening processes. Now, IonGate’s original product, SURFE2R One, is joined by the SURFE2R Workstation 500 to provide highly precise functional screening of transporters in the higher-throughput pharmaceutical discovery and development environments. IonGate provides total system solutions, encompassing disposables and reagents, consulting services which include the design of assays and customized applications, and contract laboratory services.

IonGate Biosciences GmbH is a venture capital financed biotechnology company located in Frankfurt/Main, Germany and Portland, Maine, USA. In addition to the main financier and leading partner Heidelberg Innovation, the KfW holds a stake in IonGate. The company was established in 2000 and currently employs more than 30 staff.